Arbeitsgruppe Weichteilsarkome/Knochentumoren - Über uns

The Sarcoma and GIST Working Group of the AIO is focused on the development of novel therapeutics in the field of mesenchymal tumors. Our aim is to improve the treatment of sarcoma patients, which we pursuit by testing novel concepts within clinical studies.
Most of our clinical trials and research projects represent AIO/investigator initiated trials. However, we are also open for cooperation with international institutions and associations as well as with the pharmaceutical industry. These pages give you an idea about our team and current scientific activities.  If you have interest in collaboration, feel free to contact us by Email or by phone.

Adult Soft Tissue Sarcoma

Sarcoma is a rare and often misdiagnosed disease, which may occur in different parts of the body. A proper diagnostic and therapeutic procedure is key for the successful management of this disease. Novel concepts include perioperative multimodal treatment, which are thought to improve outcome. In irresectable disease, medical treatment remains a cornerstone of therapy. Heterogeneity of sarcomas has led to histospecific treatment recommendations and drug development for sarcomas.

Spokesman:
since 2016 Sebastian Bauer, Essen
2011-2016 Viktor Grünwald, Hannover
2005-2011 Jörg Thomas Hartmann, Kiel
2002-2005 Peter Reichardt, Berlin